Lau DCW, Erichsen L, Francisco AM, Satylganova A, et al. Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial. Lancet 2021 Nov 16. pii: S0140-6736(21)01751.
PMID: 34798060